TORONTO, Aug. 23, 2017 /CNW/ - Ken Clement, Founder and Executive Chair and Aaron Keay, CEO, ABcann Global Corporation (ABCN), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. ABcann Global is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). ABcann's flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. ABcann Global Corporation commenced trading on TSX Venture Exchange on May 4, 2017.

Ken Clement, Founder and Executive Chair and Aaron Keay, CEO, ABcann Global Corporation (ABCN), joined Tim Babcock, Director, Listed Issuer Services, TSX Venture Exchange to open the market. ABcann Global is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR). ABcann’s flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. ABcann Global Corporation commenced trading on TSX Venture Exchange on May 4, 2017. (CNW Group/TMX Group Limited)

SOURCE TMX Group Limited

Copyright 2017 Canada NewsWire

Abcann Global Corporation (TSXV:ABCN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Abcann Global Corporation 차트를 더 보려면 여기를 클릭.
Abcann Global Corporation (TSXV:ABCN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Abcann Global Corporation 차트를 더 보려면 여기를 클릭.